EphA5-ephrinA5 interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local glutamine/glutamate balance during hypoglycemia

Diabetes

Volumn 62, Issue 4, 2013, Pages 1282-1288

  Szepietowska, Barbara ^a   Zhu, Wanling ^a   Czyzyk, Jan ^b   Eid, Tore ^a   Sherwin, Robert S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; EPHRIN A5; EPHRIN RECEPTOR A5; GLUCAGON; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; GLUCOSE CLAMP TECHNIQUE; GLUCOSE HOMEOSTASIS; HORMONE RELEASE; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN RELEASE; INTERSTITIAL FLUID; MALE; MICROINJECTION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; STEADY STATE; ZONA INCERTA;

ANIMALS; BLOOD GLUCOSE; EPHRIN-A5; EPINEPHRINE; GENE EXPRESSION REGULATION; GLUCAGON; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; HYPOGLYCEMIA; INSULIN; MALE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPHA5; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 84875480255     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0982     Document Type: Article

References (44)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
3. Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med 1987;316:1376-1383
4. Cryer PE. Glucose counterregulation in man. Diabetes 1981;30:261-264
5. Saccà L, Cryer PE, Sherwin RS. Blood glucose regulates the effects of insulin and counterregulatory hormones on glucose production in vivo. Diabetes 1979;28:533-536
6. Caprio S, Saccà L, Tamborlane WV, Sherwin RS. Relationship between changes in glucose production and gluconeogenesis during mild hypoglycemia in humans. Metabolism 1988;37:707-710
7. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973;182:171-173
8. DeRosa MA, Cryer PE. Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab 2004; 287:E32-E41
9. Marty N, Dallaporta M, Thorens B. Brain glucose sensing, counterregulation, and energy homeostasis. Physiology (Bethesda) 2007;22:241-251
10. Frizzell RT, Jones EM, Davis SN, et al. Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes 1993;42:1253-1261
11. Levin BE, Dunn-Meynell AA, Routh VH. CNS sensing and regulation of peripheral glucose levels. Int Rev Neurobiol 2002;51:219-258
12. Hevener AL, Bergman RN, Donovan CM. Hypoglycemic detection does not occur in the hepatic artery or liver: findings consistent with a portal vein glucosensor locus. Diabetes 2001;50:399-403
13. Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI. Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest 1994;93:1677-1682
14. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 1997;99:361-365
15. Kang L, Dunn-Meynell AA, Routh VH, et al. Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. Diabetes 2006;55:412-420
16. Levin BE, Dunn-Meynell AA, Routh VH. Brain glucosensing and the K (ATP) channel. Nat Neurosci 2001;4:459-460
17. Pocai A, Lam TK, Gutierrez-Juarez R, et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 2005;434:1026-1031
18. McCrimmon RJ, Evans ML, Fan X, et al. Activation of ATP-sensitive K+ channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. Diabetes 2005;54:3169-3174
19. Kullander K, Klein R. Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol 2002;3:475-486
20. Konstantinova I, Nikolova G, Ohara-Imaizumi M, et al. EphA-Ephrin-Amediated beta cell communication regulates insulin secretion from pancreatic islets. Cell 2007;129:359-370
21. Murai KK, Pasquale EB. Eph receptors, ephrins, and synaptic function. Neuroscientist 2004;10:304-314
22. Lemke G. A coherent nomenclature for Eph receptors and their ligands. Mol Cell Neurosci 1997;9:331-332
23. Klein R. Bidirectional modulation of synaptic functions by Eph/ephrin signaling. Nat Neurosci 2009;12:15-20
24. Murai KK, Pasquale EB. 'Eph'ective signaling: forward, reverse and crosstalk. J Cell Sci 2003;116:2823-2832
25. Murai KK, Van Meyel DJ. Neuron glial communication at synapses: insights from vertebrates and invertebrates. Neuroscientist 2007;13:657-666
26. Cooper MA, Kobayashi K, Zhou R. Ephrin-A5 regulates the formation of the ascending midbrain dopaminergic pathways. Dev Neurobiol 2009;69: 36-46
27. Wilkinson DG. Multiple roles of EPH receptors and ephrins in neural development. Nat Rev Neurosci 2001;2:155-164
28. Martone ME, Holash JA, Bayardo A, Pasquale EB, Ellisman MH. Immunolocalization of the receptor tyrosine kinase EphA4 in the adult rat central nervous system. Brain Res 1997;771:238-250
29. Theodosis DT, Poulain DA, Oliet SH. Activity-dependent structural and functional plasticity of astrocyte-neuron interactions. Physiol Rev 2008;88: 983-1008
30. Zarbalis K, Wurst W. Expression domains of murine ephrin-A5 in the pituitary and hypothalamus. Mech Dev 2000;93:165-168
31. Tremblay ME, Riad M, Bouvier D, et al. Localization of EphA4 in axon terminals and dendritic spines of adult rat hippocampus. J Comp Neurol 2007;501:691-702
32. Eberhart J, Swartz M, Koblar SA, Pasquale EB, Tanaka H, Krull CE. Expression of EphA4, ephrin-A2 and ephrin-A5 during axon outgrowth to the hindlimb indicates potential roles in pathfinding. Dev Neurosci 2000;22: 237-250
33. McCrimmon RJ, Fan X, Ding Y, Zhu W, Jacob RJ, Sherwin RS. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes 2004;53:1953-1958
34. Gerlai R, McNamara A. Anesthesia induced retrograde amnesia is ameliorated by ephrinA5-IgG in mice: EphA receptor tyrosine kinases are involved in mammalian memory. Behav Brain Res 2000;108:133-143
35. Nestor MW, Mok LP, Tulapurkar ME, Thompson SM. Plasticity of neuronglial interactions mediated by astrocytic EphARs. J Neurosci 2007;27: 12817-12828
36. Lawlor PA, Bland RJ, Mouravlev A, Young D, During MJ. Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. Mol Ther 2009;17:1692-1702
37. Tong Q, Ye C, McCrimmon RJ, et al. Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab 2007;5:383-393
38. Page KA, Arora J, Qiu M, Relwani R, Constable RT, Sherwin RS. Small decrements in systemic glucose provoke increases in hypothalamic blood flow prior to the release of counterregulatory hormones. Diabetes 2009;58: 448-452
39. Sherwin RS. Bringing light to the dark side of insulin: a journey across the blood-brain barrier. Diabetes 2008;57:2259-2268
40. Dalva MB, McClelland AC, Kayser MS. Cell adhesion molecules: signalling functions at the synapse. Nat Rev Neurosci 2007;8:206-220
41. Bouvier D, Corera AT, Tremblay ME, et al. Pre-synaptic and post-synaptic localization of EphA4 and EphB2 in adult mouse forebrain. J Neurochem 2008;106:682-695
42. Murai KK, Nguyen LN, Irie F, Yamaguchi Y, Pasquale EB. Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling. Nat Neurosci 2003;6:153-160
43. Filosa A, Paixão S, Honsek SD, et al. Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport. Nat Neurosci 2009;12:1285-1292
44. Carmona MA, Murai KK, Wang L, Roberts AJ, Pasquale EB. Glial ephrin-A3 regulates hippocampal dendritic spine morphology and glutamate transport. Proc Natl Acad Sci U S A 2009;106:12524-12529